Literature DB >> 19844200

Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?

Emidio Scarpellini1, Venanzio Valenza, Maurizio Gabrielli, Ernesto Cristiano Lauritano, Germano Perotti, Giuseppe Merra, Antonio Dal Lago, Veronica Ojetti, Maria Elena Ainora, Michele Santoro, Giovanni Ghirlanda, Antonio Gasbarrini.   

Abstract

OBJECTIVES: Impaired intestinal permeability (IP) may have a role in the pathogenesis of ascites and in spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis (LC). The aim of this study was to assess IP in LC patients with respect to healthy controls.
METHODS: IP was evaluated by the (51)Cr-ethylenediaminetetraacetic acid ((51)Cr-EDTA) permeability test in 52 LC patients and in 48 sex- and age-matched controls. The presence of (51)Cr-EDTA was also evaluated in ascitic fluid after therapeutic paracentesis in all LC patients with ascites.
RESULTS: An altered IP was found in 45% of LC patients compared with 4% of controls (P<0.00001). IP impairment was significantly associated with Child-Pugh status (75% of Child C patients vs. 39% of Child B and 22% of Child A patients), with the presence of ascites (60% in ascitic patients vs. 31% in nonascitic patients), and with a history of SBP (100% of patients with SBP vs. 50% of those without SBP). (51)Cr-EDTA was present in all ascitic samples obtained from patients with SBP compared with 22% of patients without SBP.
CONCLUSIONS: IP derangement was a common finding in LC, especially in patients with more advanced disease (presence of ascites and history of SBP). The presence of (51)Cr-EDTA in ascites in patients with SBP suggests an altered permeability of splancnic vessels and/or peritoneal membranes. Further studies are required to assess (51)Cr-EDTA urine and ascite cutoffs to set up SBP preventive strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844200     DOI: 10.1038/ajg.2009.558

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  45 in total

1.  Enterocytes' tight junctions: From molecules to diseases.

Authors:  Stelios F Assimakopoulos; Ismini Papageorgiou; Aristidis Charonis
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

Review 2.  Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.

Authors:  Mary D Cannon; Paul Martin; Andres F Carrion
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

Review 3.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

4.  Altered circadian hemodynamic and renal function in cirrhosis.

Authors:  Suthat Liangpunsakul; Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

Review 5.  Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.

Authors:  Matteo Garcovich; Maria Assunta Zocco; Davide Roccarina; Francesca Romana Ponziani; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 6.  Microbial Profiles of Cirrhosis in the Human Small Intestine.

Authors:  Tien S Dong; Jonathan P Jacobs; Shehnaz K Hussain
Journal:  Curr Gastroenterol Rep       Date:  2019-08-23

Review 7.  Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.

Authors:  Gaurav Ghosh; Arun B Jesudian
Journal:  J Clin Exp Hepatol       Date:  2018-08-27

8.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

Review 9.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

Authors:  Genta Kakiyama; William M Pandak; Patrick M Gillevet; Phillip B Hylemon; Douglas M Heuman; Kalyani Daita; Hajime Takei; Akina Muto; Hiroshi Nittono; Jason M Ridlon; Melanie B White; Nicole A Noble; Pamela Monteith; Michael Fuchs; Leroy R Thacker; Masoumeh Sikaroodi; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2013-01-16       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.